Health Care & Life Sciences » Biotechnology | Emergent Biosolutions Inc.

Emergent Biosolutions Inc. | Mutual Funds

Mutual Funds that own Emergent Biosolutions Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Core S&P Small Cap ETF
1,935,999
3.87%
549
0.25%
09/06/2018
Vanguard Small Cap Index Fund
1,064,880
2.13%
13,758
0.07%
07/31/2018
Vanguard Total Stock Market Index Fund
1,061,338
2.12%
1,426
0.01%
07/31/2018
Aberdeen Small Cap Fund
1,024,897
2.04%
0
3.43%
07/31/2018
iShares Russell 2000 ETF
943,582
1.89%
-504
0.12%
09/06/2018
SPDR S&P Biotech ETF
901,984
1.8%
2,322
0.96%
09/06/2018
Glenmede Small Cap Equity Fund
817,605
1.64%
-4,435
1.27%
04/30/2018
Vanguard Small Cap Growth Index Fund
607,642
1.22%
9,180
0.15%
07/31/2018
iShares S&P Small Cap 600 Growth ETF
604,617
1.21%
867
0.52%
09/06/2018
Government Pension Fund - Global (The)
516,628
1.03%
140,122
0%
12/31/2017

About Emergent Biosolutions

View Profile
Address
400 Professional Drive
Gaithersburg Maryland 20879
United States
Employees -
Website http://www.emergentbiosolutions.com
Updated 07/08/2019
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures that address public health and national security threats. It includes Chemical, Biological, Radiological, Nuclear and Explosive or CBRNE threats; as well as emerging infectious diseases. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.